BioPorto A/S

DB:2P4 Stock Report

Market Cap: €88.4m

BioPorto Management

Management criteria checks 0/4

BioPorto's CEO is Peter Eriksen, appointed in Jan 2024, has a tenure of 1.33 years. total yearly compensation is DKK6.45M, comprised of 69.8% salary and 30.2% bonuses, including company stock and options. directly owns 0.25% of the company’s shares, worth €222.02K. The average tenure of the management team and the board of directors is 1 years and 0.6 years respectively.

Key information

Peter Eriksen

Chief executive officer

DKK 6.4m

Total compensation

CEO salary percentage69.79%
CEO tenure1.3yrs
CEO ownership0.3%
Management average tenure1yrs
Board average tenureless than a year

Recent management updates

Recent updates

CEO Compensation Analysis

How has Peter Eriksen's remuneration changed compared to BioPorto's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2025n/an/a

-DKK 82m

Dec 31 2024DKK 6mDKK 5m

-DKK 68m

Sep 30 2024n/an/a

-DKK 61m

Mar 31 2024n/an/a

-DKK 54m

Dec 31 2023n/an/a

-DKK 56m

Sep 30 2023n/an/a

-DKK 70m

Jun 30 2023n/an/a

-DKK 78m

Mar 31 2023n/an/a

-DKK 75m

Dec 31 2022DKK 292kn/a

-DKK 76m

Sep 30 2022n/an/a

-DKK 68m

Jun 30 2022n/an/a

-DKK 62m

Mar 31 2022n/an/a

-DKK 59m

Dec 31 2021DKK 3mn/a

-DKK 57m

Sep 30 2021n/an/a

-DKK 54m

Jun 30 2021n/an/a

-DKK 60m

Mar 31 2021n/an/a

-DKK 62m

Dec 31 2020DKK 7mDKK 3m

-DKK 62m

Sep 30 2020n/an/a

-DKK 64m

Jun 30 2020n/an/a

-DKK 68m

Mar 31 2020n/an/a

-DKK 69m

Dec 31 2019DKK 6mDKK 3m

-DKK 70m

Sep 30 2019n/an/a

-DKK 61m

Jun 30 2019n/an/a

-DKK 51m

Mar 31 2019n/an/a

-DKK 43m

Dec 31 2018DKK 4mDKK 3m

-DKK 38m

Compensation vs Market: Peter's total compensation ($USD963.51K) is above average for companies of similar size in the German market ($USD494.74K).

Compensation vs Earnings: Peter's compensation has increased whilst the company is unprofitable.

CEO

Peter Eriksen (64 yo)

1.3yrs

Tenure

DKK 6,448,000

Compensation

Mr. Peter Mørch Eriksen, BBA, serves as Chief Executive Officer at BioPorto A/S. He served as a Director of BioPorto A/S since November 15, 2021 until April 30, 2024 and served as its Interim CEO from Janu...

Leadership Team

NamePositionTenureCompensationOwnership
Peter Eriksen
Chief Executive Officer1.3yrsDKK 6.45m0.25%
€ 222.0k
Niels Nielsen
Executive VP & Group CFOless than a yearDKK 4.09mno data
Gry Larsen
Executive VP & Group Chief Legal Officer1.1yrsDKK 2.88mno data
Hanne Sogaard
Head of Investor Relationsless than a yearno datano data
Jennifer Zonderman
Senior Vice President of Global Marketing & Commercialization6yrsno datano data
Ursula Klause
Senior Vice President of Global Clinical & Technical Developmentno datano datano data
Jeffrey Haas
President & CEO of BioPorto Inc.1yrno datano data

1.0yrs

Average Tenure

54yo

Average Age

Experienced Management: 2P4's management team is not considered experienced ( 1 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Jens Peter Olsen
Chairmanless than a yearno datano data
Mats Thoren
Independent Director1.1yrsDKK 183.00k0.047%
€ 41.8k
Henrik Juuel
Vice-Chairman of the Board1.1yrsDKK 183.00k0.16%
€ 145.0k
Donna Haire
Directorless than a yearno datano data

0.6yrs

Average Tenure

57yo

Average Age

Experienced Board: 2P4's board of directors are not considered experienced ( 0.6 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/16 12:07
End of Day Share Price 2025/05/16 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

BioPorto A/S is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullBrookline Capital Markets
Jyoti PrakashEdison Investment Research
Yi ChenH.C. Wainwright & Co.